Diverse factors might account for these discrepancies, including the genetic background of the mice or humans studied, microbiome composition across animal facilities, modified experimental colitis protocols, and differences in NLRP3 ablation methods (Bauer et al., 2012; Wagatsuma and Nakase, 2020). Here, NLRP3 is linked to colitis.